Allergy medication for breastfeeding mothers is a common concern, as many women experience hay fever, urticaria, or other allergic conditions whilst nursing. The reassuring news is that several treatments are considered compatible with breastfeeding when used correctly. However, not all allergy medicines carry the same safety profile, and some ingredients found in over-the-counter products should be avoided. This article outlines which antihistamines, nasal sprays, and other allergy treatments are recommended or cautioned against during breastfeeding, in line with NHS, NICE, and UKDILAS guidance.

Managing Allergies Safely While Breastfeeding

Several allergy treatments are compatible with breastfeeding when used at the lowest effective dose; non-pharmacological measures such as allergen avoidance and saline nasal rinses should be tried first.

Allergies are common, and many breastfeeding mothers will need symptom relief at some point whilst nursing their baby. The good news is that several treatment options are considered compatible with breastfeeding, provided they are used appropriately and with professional guidance where needed.

All medications taken by a breastfeeding mother have the potential to pass into breast milk to some degree. The key considerations are the concentration of the drug in breast milk, the amount the infant is likely to ingest, and the potential effect on the baby. The infant's age, weight, and overall health also influence the level of risk. Extra caution and closer monitoring are advised if your baby is premature, under one month old, has any medical conditions, or has jaundice — in these situations, seek specialist advice before starting any medication.

As a general principle, use the lowest effective dose for the shortest duration necessary, and consider taking once-daily medicines just after a feed to help minimise the amount that passes into the next feed.

Before starting any allergy medication, it is worth considering non-pharmacological measures first. These may include:

• Avoiding known allergens such as pollen, pet dander, or dust mites

• Using saline nasal rinses to relieve nasal congestion

• Applying emollients for mild allergic skin reactions

• Wearing sunglasses outdoors to reduce pollen exposure to the eyes

Where symptoms are persistent or significantly affecting quality of life, medication may be necessary. Breastfeeding mothers should always inform their GP, midwife, or pharmacist that they are nursing before starting any new treatment, including over-the-counter products.

If you or your baby experience any suspected side effects from a medication, these can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Experiencing these side effects? Our pharmacists can help you navigate them →

Which Antihistamines Are Considered Safe During Breastfeeding?

Loratadine is the first-choice antihistamine during breastfeeding, with cetirizine as an acceptable alternative; both are supported by UKDILAS and NHS guidance at standard doses.

Antihistamines are the most commonly used class of allergy medication and work by blocking histamine H1 receptors, thereby reducing symptoms such as sneezing, itching, runny nose, and watery eyes. They are broadly divided into first-generation (sedating) and second-generation (non-sedating) antihistamines, and their suitability during breastfeeding differs between these groups.

Second-generation antihistamines are generally preferred for breastfeeding mothers. The following are most commonly recommended:

• Loratadine – widely considered the first-choice antihistamine during breastfeeding. It transfers into breast milk in very small amounts and has a well-established safety profile.

• Cetirizine – another second-generation option that is generally regarded as acceptable during breastfeeding. It passes into breast milk in low quantities.

• Fexofenadine – there is more limited lactation data compared with loratadine and cetirizine. It may be used if first-line options are unsuitable, as per UKDILAS guidance, but is not generally recommended ahead of loratadine or cetirizine.

Other second-generation agents such as desloratadine and levocetirizine are sometimes used as alternatives when preferred options are not suitable, though the evidence base in breastfeeding is less extensive.

These non-sedating antihistamines are less likely to cause drowsiness in either the mother or the infant, making them preferable for daytime use. The UK Drugs in Lactation Advisory Service (UKDILAS), available via the Specialist Pharmacy Service (SPS), and the Drugs and Lactation Database (LactMed) both support the use of loratadine and cetirizine as compatible with breastfeeding when used at standard doses. NHS medicines information pages for loratadine and cetirizine also confirm their compatibility with breastfeeding at usual doses.

Not sure if this is normal? Chat with one of our pharmacists →

When starting any antihistamine, monitor your baby for signs of sedation, changes in feeding, or unusual irritability, and seek advice promptly if you have any concerns.

For localised allergic eye symptoms, sodium cromoglicate eye drops — a mast cell stabiliser rather than an antihistamine — are considered safe and are preferred over systemic treatment where symptoms are confined to the eyes.

Allergy Medications to Avoid or Use With Caution When Breastfeeding

Sedating antihistamines and oral decongestants such as pseudoephedrine should generally be avoided during breastfeeding due to risks of infant sedation and reduced milk supply.

Whilst several allergy medications are considered safe, others carry a higher risk profile and should generally be avoided during breastfeeding, or used only under close medical supervision.

First-generation (sedating) antihistamines, such as chlorphenamine and promethazine, are not recommended as first-line options for breastfeeding mothers. These older antihistamines cross into breast milk more readily and may cause:

• Drowsiness or sedation in the nursing infant

• Irritability or poor feeding in some babies

• Respiratory depression in rare cases, particularly in newborns and premature infants

If a sedating antihistamine is considered necessary — for example, for short-term use in an acute allergic reaction — this should be discussed with a healthcare professional. If one is used, avoid bedsharing with your baby and monitor them closely for sedation or feeding difficulties. Non-sedating options remain strongly preferred. Note that promethazine is contraindicated for direct administration to children under two years of age; whilst this does not constitute an absolute contraindication to maternal use during breastfeeding, the risk of infant sedation means it should be avoided where possible and only used under medical supervision.

Oral decongestants such as pseudoephedrine and phenylephrine, often found in combination cold and allergy remedies, should generally be avoided during breastfeeding. Pseudoephedrine in particular has been shown to reduce milk supply and may cause irritability in infants — it should not be used. Phenylephrine has limited evidence in breastfeeding and lower oral bioavailability, but as a precaution it is also best avoided. Many over-the-counter combination products contain these ingredients, so always check labels carefully.

If nasal congestion is severe, short-course topical nasal decongestants (such as xylometazoline or oxymetazoline nasal sprays) may be considered as an alternative to oral agents, as systemic absorption is minimal. However, use should be limited to a few days to avoid rebound congestion; seek pharmacist or GP advice before use.

Oral corticosteroids, whilst sometimes necessary for severe allergic reactions, should only be used under medical supervision during breastfeeding. Prednisolone at usual doses (for example, up to 40 mg daily) is generally considered compatible with breastfeeding; for higher doses or prolonged courses, seek specialist advice and consider timing feeds to minimise infant exposure. Intranasal corticosteroid sprays such as fluticasone or beclometasone are considered safe due to their minimal systemic absorption and are often recommended as first-line treatment for allergic rhinitis, in line with NICE CKS guidance.

NHS and NICE Guidance on Treating Allergies Whilst Breastfeeding

NICE CKS recommends intranasal corticosteroids as first-line for allergic rhinitis and loratadine or cetirizine where oral antihistamines are needed, both considered safe during breastfeeding.

In the UK, guidance on the management of allergic conditions during breastfeeding is informed by several authoritative bodies, including NICE, the NHS, and the Medicines and Healthcare products Regulatory Agency (MHRA).

NICE Clinical Knowledge Summary (CKS): Allergic rhinitis recommends intranasal corticosteroids as first-line treatment for persistent symptoms, and notes that agents such as beclometasone and fluticasone are appropriate for use during breastfeeding due to their low systemic bioavailability. Where oral antihistamines are required, loratadine or cetirizine are the preferred options. NICE CKS: Urticaria similarly supports second-generation antihistamines as first-line treatment and includes considerations for use during breastfeeding.

The NHS advises that breastfeeding mothers should consult a pharmacist or GP before taking any medication, including those available without prescription. NHS medicines information pages for individual drugs (such as loratadine and cetirizine) provide patient-facing confirmation of their compatibility with breastfeeding at usual doses.

The UKDILAS, accessible via the Specialist Pharmacy Service (SPS) at sps.nhs.uk, provides specialist advice to healthcare professionals on the safety of medicines during breastfeeding — including dedicated resources on antihistamines, decongestants, and intranasal corticosteroids — and is a valuable resource when clinical uncertainty arises.

The MHRA reminds patients and clinicians that product information leaflets may advise against use during breastfeeding as a precautionary measure, even when available evidence suggests low risk. This does not necessarily mean the medication is harmful — rather, it reflects the limited clinical trial data in this population. Healthcare professionals are encouraged to weigh the benefits of treating the mother against the theoretical risk to the infant, using the best available evidence. Suspected adverse reactions in either mother or infant should be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

When to Seek Advice From Your GP or Pharmacist

Seek GP or pharmacist advice if symptoms are severe or persistent, your baby shows unusual symptoms, or you require long-term allergy treatment or carry an adrenaline auto-injector.

For many breastfeeding mothers, mild allergy symptoms can be managed safely with over-the-counter treatments such as loratadine or cetirizine, following advice from a community pharmacist. However, there are circumstances in which it is important to seek further professional guidance before starting or continuing any allergy medication.

Contact your GP or pharmacist if:

• Your allergy symptoms are severe, persistent, or worsening despite initial treatment

• You are unsure whether a medication is safe to take whilst breastfeeding

• Your baby shows any unusual symptoms after you begin a new medication, such as excessive drowsiness, poor feeding, irritability, or skin changes

• You require long-term allergy treatment or are considering immunotherapy (desensitisation) — this is usually specialist-led, and the evidence base during breastfeeding is limited; discuss the risks and benefits with your specialist

• You have a history of anaphylaxis or carry an adrenaline auto-injector

• You are taking other medications that may interact with antihistamines or allergy treatments

In cases of anaphylaxis, use your adrenaline auto-injector immediately and call 999. Intramuscular adrenaline remains the treatment of choice and must never be withheld due to breastfeeding status — the risk to the mother's life far outweighs any theoretical risk to the infant.

If you are taking any sedating medicine, including a sedating antihistamine, avoid bedsharing with your baby.

Your pharmacist is an excellent first point of contact for straightforward queries and can advise on suitable over-the-counter options. For more complex cases, your GP may refer you to an allergy specialist or consult UKDILAS via the Specialist Pharmacy Service for tailored guidance. Breastfeeding support organisations such as the Breastfeeding Network also provide medication information sheets, including one specifically covering antihistamines, written in accessible language for mothers.

Frequently Asked Questions